(Q51034171)

27 March 2018

title

Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery. (English)

1 reference

27 March 2018

author name string

Nafiseh Saghafi

1

1 reference

27 March 2018

Nayereh Khadem

2

1 reference

27 March 2018

Taraneh Mohajeri

3

1 reference

27 March 2018

Mohamad Taghi Shakeri

4

1 reference

27 March 2018

publication date

12 May 2011

1 reference

27 March 2018

Journal of Obstetrics and Gynaecology Research

published in

1 reference

27 March 2018

volume

37

1 reference

27 March 2018

issue

10

1 reference

27 March 2018

page(s)

1342-1345

1 reference

27 March 2018

Neurologic and developmental disability after extremely preterm birth. EPICure Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

The cost of prematurity: quantification by gestational age and birth weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

The impact of preterm birth on hospital inpatient admissions and costs during the first 5 years of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

ACOG Committee Opinion. Use of progesterone to reduce preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Progestogen administration in pregnancy may prevent preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Efficacy of 17α-Hydroxyprogesterone Caproate in the Prevention of Premature Labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

17alpha-hydroxy-progesterone effects on cervical proinflammatory agents in women at risk for preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Progesterone and the risk of preterm birth among women with a short cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0756.2011.01524.X

10.1111/J.1447-0756.2011.01524.X

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018